U.S. markets closed

Sangamo Therapeutics, Inc. (SGMO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.58-0.14 (-1.44%)
At close: 4:00PM EDT
9.58 0.00 (0.00%)
After hours: 06:03PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 7/30/2021
Current
3/31/202112/31/20209/30/20206/30/2020
Market Cap (intraday) 5
1.40B1.80B2.22B1.33B1.26B
Enterprise Value 3
849.91M1.20B1.61B708.84M945.19M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
10.4514.2513.5710.329.64
Price/Book (mrq)
2.973.624.252.613.20
Enterprise Value/Revenue 3
6.4745.7262.2612.2743.85
Enterprise Value/EBITDA 7
-7.25-28.33-40.39-1.68k-27.26

Trading Information

Stock Price History

Beta (5Y Monthly) 1.72
52-Week Change 3-10.25%
S&P500 52-Week Change 335.10%
52 Week High 319.43
52 Week Low 39.05
50-Day Moving Average 310.89
200-Day Moving Average 311.94

Share Statistics

Avg Vol (3 month) 3961.01k
Avg Vol (10 day) 3860.26k
Shares Outstanding 5143.88M
Implied Shares Outstanding 6N/A
Float 119.04M
% Held by Insiders 117.34%
% Held by Institutions 156.02%
Shares Short (Jul 14, 2021) 412.35M
Short Ratio (Jul 14, 2021) 410.54
Short % of Float (Jul 14, 2021) 410.37%
Short % of Shares Outstanding (Jul 14, 2021) 48.58%
Shares Short (prior month Jun 14, 2021) 413.73M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin -94.38%
Operating Margin (ttm)-99.95%

Management Effectiveness

Return on Assets (ttm)-11.23%
Return on Equity (ttm)-28.73%

Income Statement

Revenue (ttm)131.4M
Revenue Per Share (ttm)0.93
Quarterly Revenue Growth (yoy)101.00%
Gross Profit (ttm)-62.45M
EBITDA -125.09M
Net Income Avi to Common (ttm)-124.02M
Diluted EPS (ttm)-0.88
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)587.08M
Total Cash Per Share (mrq)4.08
Total Debt (mrq)42.34M
Total Debt/Equity (mrq)9.02
Current Ratio (mrq)4.57
Book Value Per Share (mrq)3.27

Cash Flow Statement

Operating Cash Flow (ttm)120.22M
Levered Free Cash Flow (ttm)3.86M